COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study
暂无分享,去创建一个
M. V. Lopez Varela | M. Montes de Oca | J. Jardim | E. Schiavi | Alejandro Casas Herrera | Carlos Aguirre
[1] P. Burney,et al. Determinants of underdiagnosis of COPD in national and international surveys. , 2015, Chest.
[2] V. D. Boscio,et al. Detección de casos de EPOC en atención primaria en 4 países de Latinoamérica: metodología del Estudio PUMA , 2014 .
[3] R. Stirbulov,et al. COPD screening in primary care in four Latin American countries: methodology of the PUMA Study. , 2014, Archivos de bronconeumologia.
[4] R. Collins,et al. Regional variations in the prevalence and misdiagnosis of air flow obstruction in China: baseline results from a prospective cohort of the China Kadoorie Biobank (CKB) , 2014, BMJ Open Respiratory Research.
[5] C. Tam,et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD) , 2013, International journal of chronic obstructive pulmonary disease.
[6] F. Martinez,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[7] Gordon H. Guyatt,et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care , 2010, Canadian Medical Association Journal.
[8] C. Janson,et al. How often is diagnosis of COPD confirmed with spirometry? , 2010, Respiratory medicine.
[9] J. Zieliński,et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting , 2008, Thorax.
[10] J. Jardim,et al. Valores de referencia para la espirometra despus de la inhalacin de 200 g de salbutamol , 2007 .
[11] J. D. de Backer,et al. Early detection of COPD: a case finding study in general practice. , 2007, Respiratory medicine.
[12] G. Valdivia,et al. Impact of Bronchodilator Use on the Prevalence of COPD in Population-Based Samples , 2007, COPD.
[13] G. Valdivia,et al. [Spirometry reference values after inhalation of 200 microg of salbutamol]. , 2007, Archivos de bronconeumologia.
[14] A. Menezes,et al. Spirometry Reference Values After Inhalation of 200 μg of Salbutamol , 2007 .
[15] G. Valdivia,et al. Diagnostic labeling of COPD in five Latin American cities. , 2007, Chest.
[16] J. Hueto,et al. La espirometría en atención primaria en Navarra , 2006 .
[17] J. Jardim,et al. Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad , 2006 .
[18] J. Hueto,et al. [Spirometry in primary care in Navarre, Spain]. , 2006, Archivos de bronconeumologia.
[19] G. Valdivia,et al. [Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over]. , 2006, Archivos de bronconeumologia.
[20] Cesar G Victora,et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.
[21] I. Adcock,et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[22] J. Díez,et al. Fiabilidad del diagnóstico de la EPOC en atención primaria y neumología en España. Factores predictivos , 2003 .
[23] J. L. Izquierdo Alonso,et al. [Reliability of chronic obstructive pulmonary disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors]. , 2003, Archivos de bronconeumologia.